China-based Hainan Honz Pharmaceutical Co., Ltd (SHE: 300086) has entered into a three-year partnership with Indonesia’s Global Putra International (GPI). The strategic collaboration is focused on multiple fronts, aiming to expand Hainan Honz’s pediatric and maternity medicines into overseas markets through the Regional Comprehensive Economic Partnership (RCEP) and Hainan free trade port. Concurrently, the partnership will facilitate the introduction of high-quality Indonesian goods and raw materials into China.
Partnership Structure and Roles
Under the terms of the agreement, Hainan Honz will be responsible for integrating local resources in Hainan, including seeking policy support and relevant preferential treatments. GPI, leveraging its strengths in Indonesia, will utilize local resources and aim to capitalize on ASEAN international trade supply chain and customs clearance preferential policies, distribution channels, and ports.
GPI’s Industry Leadership
GPI is the largest logistics company in Indonesia and a leading international e-commerce player. It is also the first company to establish a partnership with a Chinese firm in China since the two nations restored their diplomatic relations. This partnership marks a significant milestone in strengthening bilateral trade and cooperation between China and Indonesia.-Fineline Info & Tech
